AlphAIAlphAI — Financial news for AI agents
cnbc.comSEP 171 min read$WT

WisdomTree and MoonPay team up on tokenization strategy: 'Everything's going on-chain'

WisdomTree and MoonPay have partnered to expand U.S. access to tokenized funds, focusing on WisdomTree's tokenized money market mutual fund, WTGXX. Caroline Pham, CEO of MoonPay Institutional, discussed the future of digital asset regulation following the stall of the Clarity Act in the Senate.

Original reporting
cnbc.com
Published Sep 17, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 11:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefTechnology
Primary signal
$WT
Neutral
medium confidence
Mentioned
$WT
Relevance
6/10
AlphAI data visualization · based on cnbc.com
Decision brief

The 30-second read

$WTNeutralLow
01

Why it matters

The partnership aims to bridge traditional funds with on‑chain access, potentially expanding user bases for both firms.

02

Market read

A new collaboration that could influence the tokenized asset niche, but immediate market impact is limited.

03

What to watch

Regulatory clarity on digital assets remains uncertain, which could hinder rollout.

Relevance 6/10Novelty 6/10Timing: recent announcement

Background

WisdomTree runs tokenized money‑market funds; MoonPay provides crypto on‑ramp services.

Company-level read

Ticker impact

$WTNeutralMedium confidence
Context

WisdomTree announced a partnership with MoonPay to expand tokenized fund access.

Expected impact

Modest upside for WT if tokenization gains traction.

Evidence & confidence

Partnership may broaden investor base but scale and timing are unclear.

Market effects

Sector

May boost interest in tokenized asset platforms and digital fund distribution.

Regional

U.S. investors gain more access to tokenized funds, modest regional effect.

Global

Highlights growing convergence of traditional finance and crypto infrastructure.

Counterpoint

What could challenge this read

Tokenization adoption could be slower than expected, limiting upside.

Key entities

  • Company
    WisdomTree

    Asset manager offering tokenized funds.

  • Company
    MoonPay

    Crypto on‑ramp and payment platform.

Read at source← All news

Related articles

JUL 31
$WTMed

WisdomTree, Inc. (WT): Results of Operations and Financial Condition

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju

SEC EDGAR 8-K6 min
JUL 31
$WTMed

WisdomTree (NYSE:WT) Delivers Strong Q2 CY2026 Numbers

Asset management firm WisdomTree (NYSE: WT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 57.3% year on year to $177.2 million. Its non-GAAP profit of $0.31 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy WisdomTree? Find out by accessing our full research report, it’s free. "The second quarter demonstrated the quality of WisdomTree's growth.

financialcontent.com3 min
JUN 5
$WTMedAI 8/10

WisdomTree (WT) Launches Physical AI, Humanoids, Drones ETF (WDRN) Focused on Real-World Automation

WisdomTree (NYSE:WT) launched the Physical AI, Humanoids, and Drones ETF (WDRN) on May 14, targeting companies applying AI to physical tasks. The fund has a 0.45% expense ratio and focuses on humanoid robotics, autonomous drones, smart manufacturing, and logistics automation, using a rules-based, quarterly rebalanced index. The report says it aims to track the shift from digital AI to real-world automation.

finance.yahoo.com4 min
SEP 17
$METAMed

Meta Just Launched a New Subscription Business Built Entirely Around AI. Here's Why It Could Be a Game-Changer.

Meta Platforms (META) launched Meta One, a subscription service offering expanded AI features across Facebook, Instagram, and WhatsApp. Plans range from $7.99 to $499 per month. The move aims to diversify revenue as Meta faces high AI infrastructure costs and relies heavily on advertising. Meta's Q2 revenue rose 28% to $60.8B, but net income fell 15%. Analysts expect Q3 revenue of $73.66B.

fool.com3 min
SEP 17
$BIIBMedAI 8/10

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-M

Biogen Inc. (BIIB) reported that EMPAVELI (pegcetacoplan) showed a 75% relative reduction in proteinuria in adolescents with C3G or primary IC-MPGN in a Phase 3 study. The FDA recently expanded EMPAVELI's label to include reducing kidney function loss in patients aged 12 and older. The drug is the only approved treatment for these conditions in adolescents, according to the company.

leaderpost.com2 min
SEP 17
$ABBVMed

Atogepant associated with reduced menstrual migraine days

AbbVie's atogepant (Qulipta) showed significant reductions in menstrual migraine days in a Phase 3 study. Patients saw a 1.2-day reduction vs. 0.4 days for placebo. The study met all secondary endpoints, including headache days and functional disability. AbbVie plans to assess long-term effects in an extension study. No new safety concerns were reported.

healio.com2 min